Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002797091 | SCV003195971 | pathogenic | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2022-05-27 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with VHL-related conditions. This sequence change creates a premature translational stop signal (p.His110Glnfs*22) in the VHL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VHL are known to be pathogenic (PMID: 8956040, 12202531, 29891534, 31350093). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. |